ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug ...
U.S. orthopedic soft tissue repair hit $2.3B in 2024, projected near $3.4B by 2031, driven by outpatient arthroscopy ...
ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results